Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Coronary risk estimates and decisions on lipid-lowering treatment in primary prevention: Comparison between general practitioners, internists, and cardiologists
European Journal of Internal Medicine , 09/29/09
Vancheri F et al. – When presented with the same set of clinical cases, GPs, internists and cardiologists make different quantitative risk estimates and come to different conclusions about the need for lipid–lowering treatment. This may result in over– or under–prescription of lipid–lowering drugs and inconsistencies in the care provided by different categories of doctors.
Related Articles
Economic evaluation of the direct healthcare cost savings resulting from the use of walking interventions to prevent coronary heart disease in Australia
International Journal of Health Care Finance and Economics, 11/09/09
Relevance Score: 96%
Realising the potential of the family history in risk assessment and primary prevention of coronary heart disease in primary care: ADDFAM study protocol
BMC Health Services Research, 10/14/09
Relevance Score: 94%
Acute Coronary Syndromes: Diagnosis and Management, Part II
Mayo Clinic Proceedings, 11/03/09
Relevance Score: 93%
Women with chronic kidney disease more likely than men to go undiagnosed
EurekAlert, 11/02/09
Relevance Score: 93%
Development of a health-related lifestyle self-management intervention for patients with coronary heart disease
Heart & Lung; The Journal of Acute and Critical Care, 10/06/09
Relevance Score: 93%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Prevalence of Inappropriate Use of Digoxin in 136 Patients on Digoxin and Prevalence of Use of Warfarin or Aspirin in 89 Patients With Persistent or Paroxysmal Atrial Fibrillation
American Journal of Therapeutics, 11/25/09
Correlation of paramedic administration of furosemide with emergency physician diagnosis of congestive heart failure
Journal of Emergency Primary Health Care, 11/24/09
Today in Coronary Artery Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Extremes of Endogenous Testosterone Are Associated with Increased Risk of Incident Coronary Events in Older Women
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Ring-Calcification of Giant Coronary Artery Aneurysm of an 11-Year-Old Child with History of Kawasaki Disease
Pediatric Cardiology, 11/25/09
The role of platelets CD40 ligand (CD154) in acute coronary syndromes
Thrombosis Research, 11/25/09
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels
Diabetes Care, 11/23/09
Low Total and Nonheme Iron Intakes Are Associated with a Greater Risk of Hypertension
The Journal of Nutrition, 11/19/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


